Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Vireo Growth ( (TSE:VREO) ) has issued an announcement.
Vireo Growth Inc. reported a 1.9% year-over-year increase in Q1 2025 revenue, reaching $24.5 million, aligning with expectations for its established markets. The company is set to begin closing merger transactions in Q2, which are anticipated to enhance its profitability profile. The financial results showed growth in Maryland and stable performance in Minnesota, while New York experienced a decline in medical sales but commenced adult-use sales. Vireo has obtained necessary regulatory approvals for its Utah transactions and is working towards fulfilling other closing conditions for its merger transactions, expected to complete in Q2 2025.
More about Vireo Growth
Vireo Growth Inc., founded in 2014, is a pioneer in the medical cannabis industry. The company is driven by an entrepreneurial spirit and focuses on empowering local market leaders and strategic allocation of resources. Vireo is committed to serving its stakeholders, including customers, employees, shareholders, industry collaborators, and communities.
Average Trading Volume: 28,941
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$194.7M
See more insights into VREO stock on TipRanks’ Stock Analysis page.